Check Cap Ltd
NASDAQ:CHEK
Check Cap Ltd
NASDAQ:CHEK
Price:
147
USD
1.38%
Market Cap:
$9.1m
Check Cap Ltd
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Check Cap Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Check Cap Ltd
NASDAQ:CHEK
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Research & Development
-$9.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Research & Development
-$13.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Research & Development
-$15.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Research & Development
-$27m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Research & Development
-$10.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Check Cap Ltd
Glance View
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 81 full-time employees The company went IPO on 2015-02-19. The firm develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
CHEK
Intrinsic Value
4.29
USD
Overvaluation 97%
